These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11156560)

  • 61. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of the platelet ADP receptor targeted by antithrombotic drugs.
    Hollopeter G; Jantzen HM; Vincent D; Li G; England L; Ramakrishnan V; Yang RB; Nurden P; Nurden A; Julius D; Conley PB
    Nature; 2001 Jan; 409(6817):202-7. PubMed ID: 11196645
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 64. P2Y12 receptor stimulation inhibits beta-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B.
    Van Kolen K; Slegers H
    J Neurochem; 2004 Apr; 89(2):442-53. PubMed ID: 15056287
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor.
    Dobesh PP
    Pharmacotherapy; 2009 Sep; 29(9):1089-102. PubMed ID: 19698014
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The P2 receptors and congenital platelet function defects.
    Cattaneo M
    Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
    Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
    Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
    Shi XP; Yin KC; Gardell SJ
    Thromb Res; 1995 Feb; 77(3):235-47. PubMed ID: 7740516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
    Mousa SA; Jeske WP; Fareed J
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):170-6. PubMed ID: 20299391
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
    Nylander S; Mattsson C; Ramström S; Lindahl TL
    Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets.
    Lova P; Paganini S; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2002 Apr; 277(14):12009-15. PubMed ID: 11815620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
    Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
    Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor.
    Hoffmann K; Lutz DA; Straßburger J; Baqi Y; Müller CE; von Kügelgen I
    J Thromb Haemost; 2014 Nov; 12(11):1898-905. PubMed ID: 25186974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Limited usefulness of the PFA-100 for the monitoring of ADP receptor antagonists--in vitro experience.
    Golanski J; Pluta J; Baraniak J; Watala C
    Clin Chem Lab Med; 2004 Jan; 42(1):25-9. PubMed ID: 15061376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
    Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
    J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.